News
Dr Reddy's Laboratories Ltd.'s formulations manufacturing facility was given "Form 483" with seven observations from the ...
The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...
The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results